Ruofei Liang

486 total citations
23 papers, 357 citations indexed

About

Ruofei Liang is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Ruofei Liang has authored 23 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Ruofei Liang's work include Glioma Diagnosis and Treatment (13 papers), Meningioma and schwannoma management (5 papers) and Epilepsy research and treatment (4 papers). Ruofei Liang is often cited by papers focused on Glioma Diagnosis and Treatment (13 papers), Meningioma and schwannoma management (5 papers) and Epilepsy research and treatment (4 papers). Ruofei Liang collaborates with scholars based in China and United States. Ruofei Liang's co-authors include Liu Yanhui, Qing Mao, Yuan Yang, Li Mao, Junhong Li, Yanhui Liu, Yunhe Mao, Xiang Wang, Xiang Wang and Qing Mao and has published in prestigious journals such as Clinica Chimica Acta, Oncotarget and BMC Cancer.

In The Last Decade

Ruofei Liang

23 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruofei Liang China 12 161 97 94 78 67 23 357
Marta Perek‐Polnik Poland 14 193 1.2× 216 2.2× 61 0.6× 61 0.8× 48 0.7× 32 471
Danielle Golub United States 9 136 0.8× 117 1.2× 91 1.0× 45 0.6× 60 0.9× 45 401
Dali Sui China 10 184 1.1× 55 0.6× 96 1.0× 46 0.6× 72 1.1× 17 367
Seung-Ho Yang South Korea 14 115 0.7× 105 1.1× 36 0.4× 68 0.9× 62 0.9× 45 518
Francesca Castiglione Italy 12 115 0.7× 110 1.1× 56 0.6× 51 0.7× 57 0.9× 40 445
Mary Welch United States 12 237 1.5× 64 0.7× 57 0.6× 108 1.4× 27 0.4× 37 405
Anna F. Piotrowski United States 11 127 0.8× 60 0.6× 53 0.6× 176 2.3× 33 0.5× 26 374
Barbara O’Brien United States 14 239 1.5× 108 1.1× 53 0.6× 180 2.3× 34 0.5× 56 478
Federica Franchino Italy 10 153 1.0× 48 0.5× 30 0.3× 113 1.4× 50 0.7× 19 333
Yahya Ahmadipour Germany 14 172 1.1× 41 0.4× 32 0.3× 47 0.6× 84 1.3× 55 395

Countries citing papers authored by Ruofei Liang

Since Specialization
Citations

This map shows the geographic impact of Ruofei Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruofei Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruofei Liang more than expected).

Fields of papers citing papers by Ruofei Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruofei Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruofei Liang. The network helps show where Ruofei Liang may publish in the future.

Co-authorship network of co-authors of Ruofei Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruofei Liang. A scholar is included among the top collaborators of Ruofei Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruofei Liang. Ruofei Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Huijun, Yi He, Ruofei Liang, et al.. (2021). A meta-analysis and systematic review of intracranial pressure monitoring on severe craniocerebral injury. Annals of Palliative Medicine. 10(5). 5380–5390. 5 indexed citations
2.
Li, Junhong, Ruofei Liang, Song Chen, Yufan Xiang, & Yan‐Hui Liu. (2019). Prognostic Value of Ki-67/MIB-1 Expression in Meningioma Patients: A Meta-Analysis. Critical Reviews in Eukaryotic Gene Expression. 29(2). 141–150. 11 indexed citations
3.
Liang, Ruofei, et al.. (2019). A comprehensive study of risk factors for post-operative pneumonia following resection of meningioma. BMC Cancer. 19(1). 100–100. 18 indexed citations
4.
Li, Junhong, et al.. (2018). Prognostic and clinicopathological significance of long non-coding RNA in glioma. Neurosurgical Review. 43(1). 1–8. 17 indexed citations
5.
Xiang, Yang, Ruofei Liang, & Yuekang Zhang. (2018). An unusual complication of ventriculoperitoneal shunt with bladder perforation and extrusion through the urethra orifice in an adult male patient. International Journal of Neuroscience. 129(1). 101–102. 10 indexed citations
6.
Liang, Ruofei, Li Mao, Yuan Yang, et al.. (2017). Circulating miR-128 as a potential diagnostic biomarker for glioma. Clinical Neurology and Neurosurgery. 160. 88–91. 17 indexed citations
7.
Liang, Ruofei, Junhong Li, Li Mao, Yuan Yang, & Liu Yanhui. (2017). The prognostic role of controlling nutritional status scores in patients with solid tumors. Clinica Chimica Acta. 474. 155–158. 47 indexed citations
8.
Liang, Ruofei, Ni Chen, Li Mao, et al.. (2017). Significance of systemic immune-inflammation index in the differential diagnosis of high- and low-grade gliomas. Clinical Neurology and Neurosurgery. 164. 50–52. 21 indexed citations
9.
Liang, Ruofei, Li Mao, Yuan Yang, Qing Mao, & Liu Yanhui. (2017). Significance of Pretreatment Red Blood Cell Distribution Width in Patients with Newly Diagnosed Glioblastoma. Medical Science Monitor. 23. 3217–3223. 12 indexed citations
10.
Liang, Ruofei, Junhong Li, Li Mao, et al.. (2017). Clinical significance of pre-surgical serum lipid levels in patients with glioblastoma. Oncotarget. 8(49). 85940–85948. 8 indexed citations
11.
Yang, Yuan, et al.. (2016). Dysregulation of microRNA-128 expression in WHO grades 2 glioma is associated with glioma-associated epilepsy. Epilepsy Research. 127. 6–11. 17 indexed citations
12.
Yang, Yuan, et al.. (2016). Activation of the mTOR signaling pathway in peritumoral tissues can cause glioma-associated seizures. Neurological Sciences. 38(1). 61–66. 11 indexed citations
13.
Yang, Yuan, et al.. (2016). Mapping genetic factors in high-grade glioma patients. Clinical Neurology and Neurosurgery. 150. 159–163. 4 indexed citations
14.
Yang, Yuan, Qi Chen, Xiang Wang, et al.. (2016). TERT mutation in glioma: Frequency, prognosis and risk. Journal of Clinical Neuroscience. 26. 57–62. 38 indexed citations
15.
Yang, Yuan, Peizhi Zhou, Lang Wu, et al.. (2015). The efficacy of levetiracetam for patients with supratentorial brain tumors. Journal of Clinical Neuroscience. 22(8). 1227–1231. 12 indexed citations
16.
Yang, Yuan, Yunhe Mao, Xiang Wang, et al.. (2014). P450 enzyme-inducing and non-enzyme-inducing antiepileptic drugs for seizure prophylaxis after glioma resection surgery: A meta-analysis. Seizure. 23(8). 616–621. 10 indexed citations
17.
Liang, Ruofei, et al.. (2014). Potential role of fractional anisotropy derived from diffusion tensor imaging in differentiating high-grade gliomas from low-grade gliomas: a meta-analysis.. PubMed. 7(10). 3647–53. 6 indexed citations
18.
Liang, Ruofei, Xiang Wang, Mao Li, et al.. (2014). The potential risk factors for atypical and anaplastic meningiomas: clinical series of 1,239 cases.. PubMed. 7(12). 5696–700. 27 indexed citations
19.
Liang, Ruofei, et al.. (2013). The Significance of IDH1 Mutations in Tumor‐Associated Seizure in 60 Chinese Patients with Low‐Grade Gliomas. The Scientific World JOURNAL. 2013(1). 403942–403942. 20 indexed citations
20.
Yang, Yuan, Xiang Wang, Liu Yanhui, et al.. (2013). Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control. Seizure. 22(10). 877–881. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Perek‐Polnik Breakdown of academic impact, for papers by Danielle Golub Breakdown of academic impact, for papers by Dali Sui Breakdown of academic impact, for papers by Seung-Ho Yang Breakdown of academic impact, for papers by Francesca Castiglione Breakdown of academic impact, for papers by Mary Welch Breakdown of academic impact, for papers by Anna F. Piotrowski Breakdown of academic impact, for papers by Barbara O’Brien Breakdown of academic impact, for papers by Federica Franchino Breakdown of academic impact, for papers by Yahya Ahmadipour
Rankless by CCL
2026